121 related articles for article (PubMed ID: 12693360)
1. Nevirapine found to be as effective as efavirenz.
TreatmentUpdate; 2003; 15(2):3-4. PubMed ID: 12693360
[No Abstract] [Full Text] [Related]
2. [CROI--presentation of new study results. In a comparison of NNRTI nevirapine is equally effective].
MMW Fortschr Med; 2004 Apr; 146 Spec No 1():91. PubMed ID: 15373068
[No Abstract] [Full Text] [Related]
3. Comparison of NNRTIs in antiretroviral-naïve patients.
Arribas J
Int J STD AIDS; 2001 Nov; 12 Suppl 4():3-9. PubMed ID: 11589822
[No Abstract] [Full Text] [Related]
4. [The use of the non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz in the treatment of patients with a chronic HIV-I infection].
van Leth F; Lange JM
Ned Tijdschr Geneeskd; 2006 Aug; 150(31):1719-22. PubMed ID: 16924943
[TBL] [Abstract][Full Text] [Related]
5. Report from the Tenth Retrovirus Conference. Comparing efavirenz and nevirapine: the 2NN study.
Sax PE
AIDS Clin Care; 2003 Apr; 15(4):32. PubMed ID: 12712946
[No Abstract] [Full Text] [Related]
6. Swiss study switching to efavirenz.
TreatmentUpdate; 2002 Feb; 14(2):1-2. PubMed ID: 12691037
[No Abstract] [Full Text] [Related]
7. Switching from protease inhibitors to the non-nuke efavirenz.
TreatmentUpdate; 2001; 12(12):3. PubMed ID: 11570089
[No Abstract] [Full Text] [Related]
8. [Efavirenz--comprehensive status of studies].
MMW Fortschr Med; 2005 Apr; 147 Spec No 1():79-81. PubMed ID: 16385886
[No Abstract] [Full Text] [Related]
9. Can early failure with nevirapine be rescued with efavirenz?
Briones C; Soriano V; Dona C; Barreiro P; González-Lahoz J
J Acquir Immune Defic Syndr; 2000 May; 24(1):76-8. PubMed ID: 10877499
[No Abstract] [Full Text] [Related]
10. Anti-HIV agents. Efavirenz versus indinavir: who really wins?
TreatmentUpdate; 2000 Feb; 12(1):4-5. PubMed ID: 12125628
[No Abstract] [Full Text] [Related]
11. Nevirapine or efavirenz combined with two nucleoside reverse transcriptase inhibitors compared to HAART: a meta-analysis of randomized clinical trials.
Torre D; Tambini R; Speranza F
HIV Clin Trials; 2001; 2(2):113-21. PubMed ID: 11590519
[TBL] [Abstract][Full Text] [Related]
12. Nevirapine plus efavirenz plus didanosine: a simple, safe, and effective once-daily regimen for patients with HIV infection.
Jordan WC; Jefferson R; Yemofio F; Tolbert L; Conlon V; Carroll H; Green DC; Green A; Green R
J Natl Med Assoc; 2003 Dec; 95(12):1152-7. PubMed ID: 14717471
[TBL] [Abstract][Full Text] [Related]
13. Nevirapine versus efavirenz based antiretroviral treatment in naive Indian patients: comparison of effectiveness in clinical cohort.
Patel AK; Pujari S; Patel K; Patel J; Shah N; Patel B; Gupte N
J Assoc Physicians India; 2006 Dec; 54():915-8. PubMed ID: 17334006
[TBL] [Abstract][Full Text] [Related]
14. Experience with efavirenz in end-stage renal disease.
Das S; Ghanem M; Huengsberg M
Int J STD AIDS; 2004 Feb; 15(2):143. PubMed ID: 15006080
[No Abstract] [Full Text] [Related]
15. The nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in the treatment of HIV.
Sheran M
HIV Clin Trials; 2005; 6(3):158-68. PubMed ID: 16192249
[TBL] [Abstract][Full Text] [Related]
16. Comparing liver toxicity between efavirenz and nevirapine.
TreatmentUpdate; 2002 Feb; 14(2):7-8. PubMed ID: 12691044
[No Abstract] [Full Text] [Related]
17. Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection.
Martínez E; Arnaiz JA; Podzamczer D; Dalmau D; Ribera E; Domingo P; Knobel H; Riera M; Pedrol E; Force L; Llibre JM; Segura F; Richart C; Cortés C; Javaloyas M; Aranda M; Cruceta A; de Lazzari E; Gatell JM;
N Engl J Med; 2003 Sep; 349(11):1036-46. PubMed ID: 12968087
[TBL] [Abstract][Full Text] [Related]
18. [Efavirenz and nevirapine plasma levels in HIV-infected patients with hemophilia].
Martorell M; López RM; Ribera E; Ruiz I; Tural C; Puig L; Monterde J
Enferm Infecc Microbiol Clin; 2005; 23(6):349-52. PubMed ID: 15970167
[TBL] [Abstract][Full Text] [Related]
19. Higher virological effectiveness of NNRTI-based antiretroviral regimens containing nevirapine or efavirenz compared to a triple NRTI regimen as initial therapy in HIV-1-infected adults.
Pérez-Elías MJ; Moreno A; Moreno S; López D; Antela A; Casado JL; Dronda F; Gutiérrez C; Quereda C; Navas E; Abraira V; Rodríguez MA
HIV Clin Trials; 2005; 6(6):312-9. PubMed ID: 16452065
[TBL] [Abstract][Full Text] [Related]
20. Protease inhibitor-sparing regimens: new evidence strengthens position.
Moyle GJ
J Acquir Immune Defic Syndr; 2003 Jun; 33 Suppl 1():S17-25; quiz S26-8. PubMed ID: 12946062
[No Abstract] [Full Text] [Related]
[Next] [New Search]
